<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestnovsu</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Новгородского государственного университета</journal-title><trans-title-group xml:lang="en"><trans-title>Vestnik of Novgorod State University</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-8052</issn><publisher><publisher-name>Новгородский государственный университет имени Ярослава Мудрого</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.34680/2076-8052.2022.2(127).94-97</article-id><article-id custom-type="elpub" pub-id-type="custom">vestnovsu-132</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Восстановительная медицина. Спортивная медицина</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative medicine. Sports medicine</subject></subj-group></article-categories><title-group><article-title>Особенности клиники и течения легкой формы коронавирусной инфекции</article-title><trans-title-group xml:lang="en"><trans-title>Features of the clinic and the course of mild coronaviral infection</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисенко</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisenko</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">dsstasy-98@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рисс</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Riss</surname><given-names>M. E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>N. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кропачев</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kropachev</surname><given-names>I. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Новгородский государственный университет имени Ярослава Мудрого</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Центр общей врачебной (семейной) практики №3 поликлиники №4</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>20</day><month>09</month><year>2023</year></pub-date><volume>0</volume><issue>2(127)</issue><fpage>94</fpage><lpage>97</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Денисенко А.С., Рисс М.Е., Никитина Н.Н., Кропачев И.Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Денисенко А.С., Рисс М.Е., Никитина Н.Н., Кропачев И.Г.</copyright-holder><copyright-holder xml:lang="en">Denisenko A.S., Riss M.E., Nikitina N.N., Kropachev I.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestnovsu.elpub.ru/jour/article/view/132">https://vestnovsu.elpub.ru/jour/article/view/132</self-uri><abstract><p>В условиях пандемии COVID-19 практическое значение имеет изучение клинических особенностей не только тяжелой, но и легкой формы этого заболевания. Целью настоящего исследования стал анализ клинических особенностей течения легкой формы коронавирусной инфекции. Выявлено, что наиболее частыми жалобами при легкой форме COVID-19 стали субфебрильная температура, кашель, общая слабость, потеря обоняния и вкуса, насморк, боль в горле. Получены данные о возрастно-половой структуре больных легкой формой COVID-19 и о встречаемости избыточной массы тела в этой группе пациентов. Результаты исследования дополняют известную информацию, полученную при рассмотрении среднетяжелых и тяжелых форм заболевания, и подтверждают гипотезы о роли изучаемых факторов в патогенезе COVID-19.</p></abstract><trans-abstract xml:lang="en"><p>In the context of the COVID-19 pandemic, it is of practical importance to study the clinical features of not only severe, but also mild forms of this disease. The aim of this research was to study the clinical features of the course of a mild form of coronavirus infection. It was revealed that the most frequent complaints in mild COVID-19 were low-grade fever, cough, general weakness, loss of smell and taste, rhinitis, sore throat. Data were obtained on the age-sex structure of patients with mild COVID-19 and on the incidence of overweight in this group of patients. The results of the research complement the known information obtained in the study of moderate and severe forms of the disease and confirm the hypotheses about the role of the studied factors in the pathogenesis of COVID-19.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>легкая форма COVID-19</kwd><kwd>возрастно-половая структура</kwd><kwd>избыточная масса тела</kwd><kwd>лица молодого и среднего возраста</kwd><kwd>NK-активирующие рецепторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mild form of COVID-19</kwd><kwd>age-sex structure</kwd><kwd>overweight</kwd><kwd>young and middle-aged people</kwd><kwd>NK-activating receptors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020 // China CDC Weekly, 2020. Vol.2(8). P.113-122.</mixed-citation><mixed-citation xml:lang="en">The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly, 2020, vol. 2(8), pp. 113–122.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Wang X., Chen J. et al. Association of reninangiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus disease 2019 (COVID-19) infection in Wuhan, China // JAMA Cardiol. 2020. Vol.5(7). P.825-830. DOI: https://doi.org/10.1001/jamacardio.2020.1624</mixed-citation><mixed-citation xml:lang="en">Li J., Wang X., Chen J., et al. Association of reninangiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol., 2020, vol. 5(7), pp. 825–830. doi: https://doi.org/10.1001/jamacardio.2020.1624</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mehra M.R., Desai S.S., Kuy S. et al. Cardiovascular disease, drug therapy and mortality in COVID-19 // N Engl J Med. 2020. Vol.382. Article number: e102. DOI: https://doi.org/10.1056/NEJMoa2007621</mixed-citation><mixed-citation xml:lang="en">Mehra M.R., Desai S.S., Kuy S., et al. Cardiovascular disease, drug therapy and mortality in COVID-19. N. Engl. J. Med., 2020, vol. 382, art. no. e102. doi: https://doi.org/10.1056/NEJMoa2007621</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet, 2020. Vol.395(10223). P.497-506.</mixed-citation><mixed-citation xml:lang="en">Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, vol. 395(10223), pp. 497–506.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Временные методические рекомендации (версия 10 от 08.02.2021). М.: МЗ РФ, 2021. 260 с.</mixed-citation><mixed-citation xml:lang="en">Profilaktika, diagnostika i lecheniye novoy korona-virusnoy infektsii (COVID-19). Vremennyye metodi-cheskiye rekomendatsii (versiya 10 ot 08.02.2021) [Prevention, diagnosis and treatment of novel coronavirus infection (COVID-19). Temporary guidelines (version 10 dated 08.02.2021)]. Мoscow, MZ RF [Ministry of Health of the Russian Federation], 2021. 260 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мазуров В.И., Гайдукова И.З., Бакулин И.Г. и др. Особенности течения и факторы неблагоприятного прогноза коронавирусной инфекции COVID-19 у пациентов с иммуновоспалительными заболеваниями // Русский медицинский журнал. 2020. №11. С.4-8.</mixed-citation><mixed-citation xml:lang="en">Mazurov V.I., Gaidukova I.Z., Bakulin I.G. Osobennosti techeniya i faktory neblagopriyatnogo prognoza koronavirusnoy infektsii COVID-19 u pa-tsiyentov s immunovospalitel'nymi zabolevaniyami [Peculiarities of the course and factors of unfavorable prognosis of coronavirus infection COVID-19 in patients with immunoinflammatory diseases]. Russkiy meditsinskiy zhurnal — Russian Medical Journal, 2020, no. 11, pp. 4–8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Xiaoting Lu, Zhenhai Cui, Feng Pan et al. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm // Acta Diabetol. 2021. Vol.58(5). P.575-586. DOI: https://doi.org/10.1007/s00592-020-01654-x</mixed-citation><mixed-citation xml:lang="en">Xiaoting Lu, Zhenhai Cui, Feng Pan, et al. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm. Acta Diabetol., 2021, vol. 58(5), pp. 575–586. doi: https://doi.org/10.1007/s00592-020-01654-x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Акимкин В.Г., Кузин С.Н., Семененко Т.А. и др. Гендерно-возрастная характеристика пациентов с COVID-19 на разных этапах эпидемии в Москве // Проблемы особоопасных инфекций. 2020. Т.3. С.27-35. DOI: https://doi.org/10.21055/0370-1069-2020-3-27-35</mixed-citation><mixed-citation xml:lang="en">Akimkin V.G., Kuzin S.N., Semenenko T.A. Gen-dernovozrastnaya kharakteristika patsiyentov s COVID-19 na raznykh etapakh epidemii v Moskve [Gender and age characteristics of patients with COVID-19 at different stages of the epidemic in Moscow]. Problemy osobo opasnykh infektsiy — Problems of especially dangerous infections, 2020, vol.3, pp.27-35. doi: https://doi.org/10.21055/03701069-2020-3-27-35</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lieberman N.A.P, Peddu V., Xie H. et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age // PLoS Biol. 2020. Vol.18(9). Article number: e3000849. DOI: https://doi.org/10.1371/journal.pbio.3000849</mixed-citation><mixed-citation xml:lang="en">Lieberman N.A.P, Peddu V., Xie H., et al. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. PLoS Biol., 2020, vol. 18(9), art. no. e3000849. doi: https://doi.org/10.1371/journal.pbio.3000849</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Кутырев В.В., Попова А.Ю., Смоленский В.Ю. и др. Эпидемиологические особенности новой коронавирусной инфекции (COVID-19). Сообщение 1: Модели реализации профилактических и противоэпидемических мероприятий // Проблемы особо опасных инфекций. 2020. Т.1. С.6-13. DOI: https://doi.org/10.21055/0370-1069-2020-1-6-13</mixed-citation><mixed-citation xml:lang="en">Kutyrev V.V., Popova A.Yu., Smolensky V.Yu. Epidemiologicheskiye osobennosti novoy koronavi-rusnoy infektsii (COVID-19). Soobshcheniye 1: Modeli realizatsii profilakticheskikh i protivoepidemiche-skikh meropriyatiy [Epidemiological features of the new coronavirus infection (COVID-19). Message 1: Models for the implementation of preventive and anti-epidemic measures]. Problemy osobo opasnykh infektsiy — Problems of especially dangerous infections, 2020, vol. 1, pp. 6–13. doi: https://doi.org/10.21055/0370-1069-2020-1-6-13</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
